The World Conference on Lung Cancer (WCLC) is the largest and most influential global gathering focused entirely on lung cancer. This year, the conference will be held in Barcelona, Spain, where researchers, clinicians, and advocates from around the world will come together to share the latest breakthroughs in lung cancer care. 

GO2 for Lung Cancer is honored to be part of this international conversation, sharing a wide range of posters and presentations that reflect the depth and breadth of our work to impact lung cancer care across research, advocacy, support services, and patient-centered care. 

Below is a preview of the GO2 for Lung Cancer abstracts featured on this year’s program in Barcelona, organized by key themes. 

Patient voices and experience 

  • Lung Cancer Patients’ Involvement and Support Preferences and Needs: Insights from a Global Patient Experience Survey (Session: EP.16.02) 
  • Lung Cancer Patients’ Understanding of and Involvement in Their Treatment and Care: Insights from a Global Patient Experience Survey (Session: P3.16.01) 
  • Using Group Concept Mapping to Identify Research Priorities of Patient & Caregiver Stakeholders (Session: P3.16.13) 
  • Current Patient, Caregiver & Provider Attitudes Toward AI in Lung Cancer Navigation (Session: PT2.16.01) 
  • Addressing Unmet Needs of the Lung Cancer Community: The Journey to “Mind Over Matter” (Session: EP.16.07) 

Health equity and community engagement 

  • Preliminary Study of Culturally Adapted Approaches to Enhance Lung Cancer Education for Hispanic/Latino Populations (Session: EP.16.08) 
  • Health Literacy Leads to Health Equity: A Best-Practice Organizational Approach (Session: EP.16.06) 
  • The Role of Neighborhood Deprivation in Lung Cancer Treatment & Diagnosis (Session: P3.16.21) 
  • Stigma and Negativity in Lung Cancer: Is There Cause for Optimism? (Session: ES04) 

Screening and early detection 

  • Improving Lung Cancer Screening Uptake in 20 Disadvantaged New York Counties: Early Findings (Session: P3.16.20) 
  • Frontline Insights on U.S. Payer Barriers to Comprehensive Lung Cancer Screening (Session: P3.16.22) 
  • Impact of an Incidental Pulmonary Nodule Course Series on Under-Resourced Multidisciplinary Teams (Session: P2.15.30) 

Navigation and care coordination 

  • Measurable Role Transformation Following Disease-Specific Training for Multidisciplinary Lung Cancer Navigators (Session: EP.15.20)
  • Identifying Barriers to Timely Initiation of Oral Anti-Cancer Medication in NSCLC (Session: EP.17.01) 

Treatment and clinical insights 

  • Medication Adherence to Osimertinib in Metastatic NSCLC (Session: P3.12.56) 
  • Characterization of a Real-World Dataset of EGFR-Positive NSCLC Patients (Session: EP.16.03) 
  • Ready or Not: Assessing Provider & Facility Preparedness for Bispecific Therapy in ES-SCLC (Session: EP.17.08) 

We’re excited to connect with colleagues, partners, and advocates worldwide in beautiful Barcelona, Spain, to learn more and discuss how GO2 can best continue our good work impacting the lung cancer community. Whether you’ll be attending in person or following along from home, we’ll share highlights, insights, and key takeaways to keep the lung cancer community informed, inspired, and hopeful for the future.